BioSpace News Archive

Business

AcelRx Pharma Reports Third Quarter 2017 Financial Results

AcelRx Pharma today reported third quarter 2017 financial results.

November 9, 2017
·
12 min read
Business

Sophiris Bio Reports Third Quarter Financial Results and Key Corporate Highlights

The Company reported a net loss of $2.7M for the three months ended September 30, 2017 compared to a net loss of $4.3M for the three months ended September 30, 2016.

November 9, 2017
·
15 min read
Business

Pfenex Reports Third Quarter 2017 Results, Interim PK Data From PF708 Study, Completion of Process Development Milestone on Jazz Program and Provides Business Update

Using the patented Pfenex Expression Technology platform, the Company has created an advanced pipeline of therapeutic equivalents, vaccines, biologics and biosimilars.

November 9, 2017
·
18 min read
Business

Biocept Reports Third Quarter 2017 Financial Results

Biocept reports financial results for the three and nine months ended September 30, 2017, and provides an update on its business progress.

November 9, 2017
·
18 min read
Business

BioLife Solutions Announces Third Quarter 2017 Financial Results

Revenue from biopreservation media product sales for the third quarter of 2017 was a new record of $3M, an increase of 39% compared with the third quarter of 2016.

November 9, 2017
·
18 min read
Business

Achieve Reports Financial Results for Third Quarter 2017

As of September 30, 2017, the company’s cash and cash equivalents were $8M compared with $15,000 as of December 31, 2016.

November 9, 2017
·
13 min read
Business

CytoSorbents Continues Strong Trajectory of Growth in the Third Quarter 2017

Total Q3 2017 revenues increased 59% to $3.8M, which includes both product sales and grant income, up from $2.4M in Q3 2016.

November 9, 2017
·
29 min read
Business

Dextera Surgical Reports Fiscal 2018 First Quarter Financial Results

Cash and cash equivalents, as of September 30, 2017, were approximately $4.2 million, compared with approximately $6.0 million at June 30, 2017.

November 9, 2017
·
6 min read
Business

Kadmon Provides Business Update and Reports Third Quarter 2017 Financial Results

Loss from operations for the three and nine months ended September 30, 2017 was $19.8 million and $51.4 million, respectively, compared to $53.1 million and $95.8 million for the respective periods in 2016.

November 9, 2017
·
9 min read
Business

Arcadia Biosciences Announces Third-Quarter and Nine-Month 2017 Financial Results and Business Highlights

Revenues for the quarter were $589,000, 45 percent lower than the $1.1 million for the third quarter of 2016.

November 9, 2017
·
11 min read